In addition to driving expression of the LTS220A-LAMP1 fusion protein, the plasmid backbone of ITI-3000 contains CpG islands that further activate anti-tumor immune responses through ligation of foreign DNA sensing pathways. This evidence concerns the gene LAMP1 and neoplasm.